Adamas Pharmaceuticals In...

NASDAQ: ADMS · Real-Time Price · USD
8.22
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Adamas Pharmaceuticals Revenue Breakdown

Period Ending Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Product Revenue 71.17M 54.64M 34.05M
Product Revenue Growth +30.25% +60.48% n/a
Royalty Revenue 3.29M n/a n/a
Royalty Revenue Growth n/a n/a n/a

Operating Expense Breakdown

Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 29.73M 29.15M 26.64M 32.99M 26.12M 23.18M 24.55M 30.29M 31.18M 25.22M 27.69M 27.58M 27.49M 27.7M 26.36M 22.99M 16.06M 13.12M 9.14M 8.28M 7.34M 8.06M 6.64M 6.89M 5.8M 5.85M 4.92M
Selling, General, and Administrative Revenue Growth +1.99% +9.43% -19.26% +26.31% +12.70% -5.60% -18.93% -2.87% +23.65% -8.93% +0.38% +0.33% -0.75% +5.07% +14.68% +43.11% +22.49% +43.43% +10.39% +12.79% -8.86% +21.34% -3.61% +18.73% -0.74% +18.85% n/a
Research and Development Revenue 1.23M 1.45M 1.81M 2.4M 2.33M 2.55M 2.46M 5.18M 6.04M 8.6M 10.21M 10.6M 11.71M 9.81M 7.19M 6.45M 6.46M 7.18M 7.09M 7.05M 7.44M 9.22M 7.52M 9.7M 9.96M 8.71M 7.53M
Research and Development Revenue Growth -15.40% -20.09% -24.44% +2.79% -8.51% +3.45% -52.41% -14.27% -29.73% -15.82% -3.61% -9.50% +19.41% +36.42% +11.53% -0.22% -9.99% +1.24% +0.58% -5.24% -19.37% +22.63% -22.43% -2.64% +14.42% +15.56% n/a